Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2025-12-24 @ 4:18 PM
NCT ID:
NCT04274166
Brief Title:
Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum
Official Title:
The Efficacy and Safety of Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum
Study:
NCT04274166
Protocol Section:
NCT04274166